SP 16
The new European leukemianet recommendations for treating CML
Rüdiger Hehlmann
Lido
2303
Vezesque se leu este artigo
1103
Total PDF
1200
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 23 | 5 | 28 |
| 2025 5 | 70 | 22 | 92 |
| 2025 4 | 47 | 11 | 58 |
| 2025 3 | 53 | 11 | 64 |
| 2025 2 | 42 | 21 | 63 |
| 2025 1 | 50 | 24 | 74 |
| 2024 12 | 23 | 15 | 38 |
| 2024 11 | 40 | 15 | 55 |
| 2024 10 | 21 | 16 | 37 |
| 2024 9 | 41 | 17 | 58 |
| 2024 8 | 28 | 24 | 52 |
| 2024 7 | 25 | 24 | 49 |
| 2024 6 | 22 | 19 | 41 |
| 2024 5 | 24 | 28 | 52 |
| 2024 4 | 19 | 13 | 32 |
| 2024 3 | 27 | 18 | 45 |
| 2024 2 | 25 | 22 | 47 |
| 2024 1 | 28 | 26 | 54 |
| 2023 12 | 28 | 25 | 53 |
| 2023 11 | 38 | 39 | 77 |
| 2023 10 | 23 | 25 | 48 |
| 2023 9 | 16 | 35 | 51 |
| 2023 8 | 11 | 13 | 24 |
| 2023 7 | 21 | 14 | 35 |
| 2023 6 | 14 | 15 | 29 |
| 2023 5 | 25 | 21 | 46 |
| 2023 4 | 7 | 7 | 14 |
| 2023 3 | 13 | 17 | 30 |
| 2023 2 | 10 | 13 | 23 |
| 2023 1 | 12 | 6 | 18 |
| 2022 12 | 14 | 14 | 28 |
| 2022 11 | 21 | 21 | 42 |
| 2022 10 | 13 | 20 | 33 |
| 2022 9 | 25 | 27 | 52 |
| 2022 8 | 15 | 19 | 34 |
| 2022 7 | 14 | 28 | 42 |
| 2022 6 | 15 | 15 | 30 |
| 2022 5 | 17 | 19 | 36 |
| 2022 4 | 10 | 22 | 32 |
| 2022 3 | 15 | 16 | 31 |
| 2022 2 | 11 | 14 | 25 |
| 2021 1 | 8 | 12 | 20 |
| 2021 12 | 9 | 13 | 22 |
| 2021 11 | 18 | 25 | 43 |
| 2021 10 | 11 | 20 | 31 |
| 2021 9 | 15 | 27 | 42 |
| 2021 8 | 14 | 24 | 38 |
| 2021 7 | 16 | 29 | 45 |
| 2021 6 | 8 | 22 | 30 |
| 2021 5 | 23 | 30 | 53 |
| 2021 4 | 21 | 41 | 62 |
| 2021 3 | 22 | 26 | 48 |
| 2021 2 | 16 | 20 | 36 |
| 2020 1 | 10 | 13 | 23 |
| 2020 12 | 6 | 13 | 19 |
| 2020 11 | 7 | 12 | 19 |
Mostrar tudo
